Full text
PDFPage 1397
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hunt J. T., Lee V. G., Liu E. C., Moreland S., McMullen D., Webb M. L., Bolgar M. Control of peptide disulfide regioisomer formation by mixed cysteine-penicillamine bridges. Application to endothelin-1. Int J Pept Protein Res. 1993 Sep;42(3):249–258. doi: 10.1111/j.1399-3011.1993.tb00139.x. [DOI] [PubMed] [Google Scholar]
- Lakatos L. D-penicillamine and retinopathy of prematurity. Pediatrics. 1988 Dec;82(6):951–953. [PubMed] [Google Scholar]
- Matsubara T., Saura R., Hirohata K., Ziff M. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine. J Clin Invest. 1989 Jan;83(1):158–167. doi: 10.1172/JCI113853. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller J. W. Vascular endothelial growth factor and ocular neovascularization. Am J Pathol. 1997 Jul;151(1):13–23. [PMC free article] [PubMed] [Google Scholar]
- Okamoto N., Tobe T., Hackett S. F., Ozaki H., Vinores M. A., LaRochelle W., Zack D. J., Campochiaro P. A. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol. 1997 Jul;151(1):281–291. [PMC free article] [PubMed] [Google Scholar]